Abstract
Background: Autoimmune reactions are important pathogenic part for parkinsonism syndrome in chronic brain ischemia (CBI). Aims: To reveal significance of the measurement of levels of autoantibodies to neurospecific protein S100 and myelin basic protein (MBP) in blood serum of patients with parkinsonism syndrome in CBI.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
